Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

24.86
+0.19000.77%
Post-market: 24.860.00000.00%19:30 EDT
Volume:336.67K
Turnover:8.35M
Market Cap:990.97M
PE:70.67
High:25.04
Open:24.60
Low:24.49
Close:24.67
52wk High:27.66
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.73
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:1.47
PE(LYR):157.51

Loading ...

Pacira urges vote for board slate as activist DOMA pushes company sale at June 9 meeting

Reuters
·
Apr 29

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

GlobeNewswire
·
Apr 27

Pacira CFO Shawn Cross disposes of 12,941 common shares for $325,597.56

Reuters
·
Apr 25

Earning Preview: Pacira Pharmaceuticals this quarter’s revenue is expected to decrease by 1.35%, and institutional views are bullish

Earnings Agent
·
Apr 24

Pacira CFO Shawn Cross disposes 12,059 common shares for $303,299.99

Reuters
·
Apr 23

A Look At Pacira BioSciences (PCRX) Valuation After New EXPAREL Health Economic Data

Simply Wall St.
·
Apr 21

H.C. Wainwright Reaffirms Their Buy Rating on Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Apr 20

Pacira to report first-quarter results after market close, host conference call

Reuters
·
Apr 16

Pacira real-world study shows EXPAREL lowers costs in outpatient hip replacements

Reuters
·
Apr 13

Pacira to join Needham Virtual Healthcare Conference fireside chat

Reuters
·
Apr 08

Pacira grants inducement equity awards to new hires, sets options exercise price at $22.7

Reuters
·
Apr 08

Pacira says EXPAREL lowers total cost of care in real-world orthopedic studies

Reuters
·
Mar 30

Pacira BioSciences Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Mar 26

J.P. Morgan Sticks to Their Sell Rating for Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
Mar 20

Pacira BioSciences Chief Medical Officer Jonathan Slonin disposes of USD 74,411 in common shares

Reuters
·
Mar 20

Pacira BioSciences Director Mark Froimson Disposes of USD 10,905 in Common Shares

Reuters
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences

Reuters
·
Mar 12

Doma Perpetual: Asserts Frank Lee Should Be Replaced Immediately; Pacira Biosciences Board Should Name Interim CEO & Conduct Formal Sale Process

THOMSON REUTERS
·
Mar 12

Pacira BioSciences to Review Activist Investor's Proposed Board Nominees

Dow Jones
·
Mar 12

BUZZ-Pacira rises as DOMA pushes for CEO ouster, board shake-up and sale

Reuters
·
Mar 12